Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Clinical trial NCT06972511 · RECRUITING

Trial details

NCT number: NCT06972511
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Oligometastatic Prostate Cancer

Start date: 2023-08-20
Primary completion: 2025-12-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.